NRD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.549800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.771640E-01
Normal-vs-Stage2
6.034200E-01
Normal-vs-Stage3
1.918970E-01
Normal-vs-Stage4
9.671800E-01
Stage1-vs-Stage2
5.050400E-01
Stage1-vs-Stage3
3.337400E-01
Stage1-vs-Stage4
7.562000E-02
Stage2-vs-Stage3
1.370210E-01
Stage2-vs-Stage4
5.233800E-01
Stage3-vs-Stage4
1.037410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.352600E-01
Normal-vs-AfricanAmerican
9.106600E-01
Normal-vs-Asian
5.385200E-01
Caucasian-vs-AfricanAmerican
2.791000E-01
Caucasian-vs-Asian
8.255800E-01
AfricanAmerican-vs-Asian
3.867000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.950600E-01
Normal-vs-Female
7.610800E-01
Male-vs-Female
7.030400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.131000E-01
Normal-vs-Age(41-60Yrs)
9.334800E-01
Normal-vs-Age(61-80Yrs)
3.883400E-01
Normal-vs-Age(81-100Yrs)
6.081000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.018400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.336400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.703400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.771390E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.631200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.185400E-01
Normal-vs-Daily Drinker
4.615600E-01
Normal-vs-Weekly Drinker
4.569800E-01
Normal-vs-Occasional Drinker
8.973800E-01
Normal-vs-Social Drinker
7.705600E-01
Non Drinker-vs-Daily Drinker
8.210200E-01
Non Drinker-vs-Weekly Drinker
9.836600E-01
Non Drinker-vs-Occasional Drinker
1.899890E-02
Non Drinker-vs-Social Drinker
1.965420E-01
Daily Drinker-vs-Weekly Drinker
8.385600E-01
Daily Drinker-vs-Occasional Drinker
5.197900E-02
Daily Drinker-vs-Social Drinker
2.733000E-01
Weekly Drinker-vs-Occasional Drinker
9.970200E-02
Weekly Drinker-vs-Social Drinker
2.475600E-01
Occasional Drinker-vs-Social Drinker
4.173000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.982200E-01
Normal-vs-Grade 2
9.881200E-01
Normal-vs-Grade 3
9.978200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.310300E-02
Grade 1-vs-Grade 3
3.503500E-02
Grade 1-vs-Grade 4
8.982200E-01
Grade 2-vs-Grade 3
7.751000E-01
Grade 2-vs-Grade 4
9.881200E-01
Grade 3-vs-Grade 4
9.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.758200E-01
Normal-vs-NonDiabetic
5.170600E-01
Diabetic-vs-NonDiabetic
6.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.436000E-01
Normal-vs-NoPancreatitis
4.831800E-01
Pancreatitis-vs-NoPancreatitis
1.350990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.412800E-01
Normal-vs-N1
5.876400E-01
N0-vs-N1
9.702600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.876800E-01
Normal-vs-TP53-NonMutant
4.114800E-01
TP53-Mutant-vs-TP53-NonMutant
8.238600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
